{
    "root": "77bb27a8-b20e-44eb-b96c-ff1a364a24d1",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Letrozole",
    "value": "20250131",
    "ingredients": [
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A",
            "code": "H8AV0SQX4D"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "HYPROMELLOSE 2208 (100 MPA.S)",
            "code": "B1QE5P712K"
        },
        {
            "name": "LETROZOLE",
            "code": "7LKK855W8I"
        }
    ],
    "indications": "Letrozole Tablets, USP are aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer ( 1.1 ) Extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy ( 1.2 ) First and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer ( 1.3 )",
    "contraindications": "Letrozole tablets are taken orally without regard to meals ( 2 ): Recommended dose: 2.5 mg once daily ( 2.1 ) Patients with cirrhosis or severe hepatic impairment: 2.5 mg every other day ( 2.5 , 5.3 )",
    "warningsAndPrecautions": "Packaged in HDPE bottles with a safety screw cap.\n                  Letrozole Tablets, USP 2.5 mg\n                  \n                     Bottles of 30 tablets: NDC 71335-2396-1\n                     Bottles of 10 tablets: NDC 71335-2396-2\n                     Bottles of 90 tablets: NDC 71335-2396-3\n                     Bottles of 40 tablets: NDC 71335-2396-4\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions": "● Pregnancy: Letrozole can cause fetal harm \n        \n \n   [see \n         \n  \n    Use in\n                        \n                        \n                            Specific Populations (8.1)]\n        \n \n   . \n       \n\n  \n                  \n                  \n                     ● Known hypersensitivity to the active substance, or to any of the excipients \n        \n \n   [see \n         \n  \n    Adverse Reactions (6)]\n        \n \n   ."
}